Skip to main navigation Skip to search Skip to main content

Human tumor antigens recognized by T cells

  • Paul F. Robbins
  • , Yutaka Kawakami

Research output: Contribution to journal › Article › peer-review

Abstract

The ability of tumor-reactive T cells to mediate in vivo tumor regression has been demonstrated in murine tumor models and by the clinical responses to adoptive immunotherapy with tumor-infiltrating lymphocytes isolated from human melanomas. Investigations carried out in the past several years have resulted in the isolation of a number of the genes encoding antigens recognized by melanoma-reactive T cells. The ability of these products to serve as tumor regression antigens has now begun to be evaluated in clinical vaccine trials.

Original languageEnglish
Pages (from-to)628-636
Number of pages9
JournalCurrent Opinion in Immunology
Volume8
Issue number5
DOIs
Publication statusPublished - 1996 Oct
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Human tumor antigens recognized by T cells'. Together they form a unique fingerprint.

Cite this